Curanex Pharmaceuticals Inc
CURX
$4.20
-$0.84-16.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 7.83M | 5.24M | 2.98M | 677.50K | -- |
| Gross Profit | -7.83M | -5.24M | -2.98M | -677.50K | -- |
| SG&A Expenses | 2.72M | 2.05M | 1.26M | 541.80K | 361.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.55M | 7.29M | 4.24M | 1.22M | 361.20K |
| Operating Income | -10.55M | -7.29M | -4.24M | -1.22M | -361.20K |
| Income Before Tax | -10.47M | -7.24M | -4.23M | -1.30M | -435.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.47 | -7.24 | -4.23 | -1.30 | -0.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.47M | -7.24M | -4.23M | -1.30M | -435.00K |
| EBIT | -10.55M | -7.29M | -4.24M | -1.22M | -361.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -7.46 | -5.18 | -3.08 | -0.98 | -1.00 |
| Normalized Basic EPS | -4.66 | -3.24 | -1.92 | -0.59 | -0.60 |
| EPS Diluted | -7.46 | -5.18 | -3.08 | -0.98 | -1.00 |
| Normalized Diluted EPS | -4.66 | -3.24 | -1.92 | -0.59 | -0.60 |
| Average Basic Shares Outstanding | 5.53M | 5.32M | 5.10M | 5.70M | 4.54M |
| Average Diluted Shares Outstanding | 5.53M | 5.32M | 5.10M | 5.70M | 4.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |